Skip to main content

Hepatitis D and Hepatitis E in Children

  • Chapter
  • First Online:
Viral Hepatitis in Children

Part of the book series: Clinical Gastroenterology ((CG))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rizzetto M, Canese MG, Arico S, et al. Immunofluorescence detection of new antigen-­antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977;18(12):997–1003.

    PubMed  CAS  Google Scholar 

  2. Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis. 1980;141(5):590–602.

    PubMed  CAS  Google Scholar 

  3. Rizzetto M, Hoyer B, Canese MG, Shih JW, Purcell RH, Gerin JL. delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A. 1980;77(10):6124–6128.

    PubMed  CAS  Google Scholar 

  4. Wang KS, Choo QL, Weiner AJ, et al. Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature. 1986;323(6088):508–514.

    PubMed  CAS  Google Scholar 

  5. Kos A, Dijkema R, Arnberg AC, van der Meide PH, Schellekens H. The hepatitis delta (delta) virus possesses a circular RNA. Nature. 1986;323(6088):558–560.

    PubMed  CAS  Google Scholar 

  6. Chen PJ, Kalpana G, Goldberg J, et al. Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A. 1986;83(22):8774–8778.

    PubMed  CAS  Google Scholar 

  7. Lai MM. The molecular biology of hepatitis delta virus. Annu Rev Biochem. 1995;64:259–286.

    PubMed  CAS  Google Scholar 

  8. Radjef N, Gordien E, Ivaniushina V, Gault E, Anais P, Drugan T, et al. Molecular phylogenetic analyses indicate a wide and ancient rediation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol. 2004;78:2537–2544.

    PubMed  CAS  Google Scholar 

  9. Branch AD, Robertson HD. A replication cycle for viroids and other small infectious RNA’s. Science. 1984;223(4635):450–455.

    PubMed  CAS  Google Scholar 

  10. Taylor J NF, Rizetto M. Hepatitis delta virus: from structure to disease expression. Rev Med Virol. 1992;2:161–167.

    Google Scholar 

  11. Le Gal F Gault E, Ripault MP, Serpaggi J, Trinchet JC, Gordien E, Deny P. Eighth major clade for hepatitis delta virus. Emerg Infect Dis. 2006;12(9):1447–1450.

    PubMed  Google Scholar 

  12. Deny P. Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades? Curr Top Microbiol Immunol. 2006;307:151–171.

    PubMed  CAS  Google Scholar 

  13. Hadziyannis S. Review: hepatitis delta. J Gastroenterol and Hepatol. 1997;12(4):289–298.

    CAS  Google Scholar 

  14. Ryu WS, Netter H, Bayer M et al. Ribonucleoprotein complexes of hepatitis delta virus. J Virol. 1993;67(6):3281–8287.

    PubMed  CAS  Google Scholar 

  15. Binchko V, Netter HJ, Wu TT, et. a. Pathogenesis associated with replication of hepatitis delta virus. Infect Agents Dis. 1994;3(2–3):94–97.

    Google Scholar 

  16. Jacobsen IM, Dienstag J. The delta hepatitis agent: viral hepatitis, type D. Gastroenterology. 1984;86:1614–1616.

    Google Scholar 

  17. Rizzetto M, Durazzo M. Hepatitis Delta virus(HDV) infections. Epidemiological and clinical heterogeneity. J Hepatol. 1991;13(Suppl 4):S116–S118.

    PubMed  Google Scholar 

  18. Rosina F, Conoscitore P, Cuppone R, et al. Changing pattern of chronic hepatitis D in southern Europe. Gastroenterology. 1999;117:161–166.

    PubMed  CAS  Google Scholar 

  19. Navascues C, Rodriguez M, Sottorio N, et al. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol. 1995;90:1981–1984.

    PubMed  CAS  Google Scholar 

  20. Gaeta GB, Stroffolini T, Chiaramonte M, et al. Chronic hepatitis D: a vanishing disease? An italian multicenter study. Hepatology. 2000;32:824–827.

    PubMed  CAS  Google Scholar 

  21. Sagnelli E, Stroffolini T, Ascione A, et al. Decrease in HDV endemicity in Italy. J Hepatol. 1997;26(1):20–24.

    PubMed  CAS  Google Scholar 

  22. Navascues CA, Rodriguez M, Sotorrio NG, et al. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol. 1995;90(11):1981–1984.

    PubMed  CAS  Google Scholar 

  23. Degertekin H, Yalcin K, Yakut M. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies. Turk J Gastroenterol. 2006;17(1):25–34.

    PubMed  Google Scholar 

  24. Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD. Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol. 1997;12(11):747–751.

    PubMed  CAS  Google Scholar 

  25. Cross TJ, Rizzi P, Horner M, et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol. 2008;80(2):277–282.

    PubMed  Google Scholar 

  26. Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infection – not a vanishing disease in Europe! Hepatology. 2007;45(5):1331–1332.

    PubMed  Google Scholar 

  27. Gaeta GB, Stroffolini T, Smedile A, Niro G, Mele A. Hepatitis delta in Europe: vanishing or refreshing? Hepatology. 2007;46(4):1312–1313.

    PubMed  Google Scholar 

  28. Stroffolini T, Ferrigno L, Cialdea L, et al. Incidence and risk factors of acute Delta hepatitis in Italy: results from a national surveillance system. SEIEVA Collaborating Group. J Hepatol. 1994;21(6):1123–1126.

    PubMed  CAS  Google Scholar 

  29. Weisfuse IB, Hadler SC, Fields HA, et al. Delta hepatitis in homosexual men in the United States. Hepatology. 1989;9(6):872–874.

    PubMed  CAS  Google Scholar 

  30. Niro GA, Casey JL, Gravinese E, et al. Intrafamilial transmission of hepatitis delta virus: molecular evidence. J Hepatol. 1999;30(4):564–569.

    PubMed  CAS  Google Scholar 

  31. Hsu HY, Chang MH, Chen DS, Lee CY. Hepatitis D virus infection in children with acute or chronic hepatitis B virus infection in Taiwan. J Pediatr. 1988;112(6):888–892.

    PubMed  CAS  Google Scholar 

  32. Smedile A, Farci P, Verme G, et al. Influence of delta infection on severity of hepatitis B. Lancet. 1982;2(8305):945–947.

    PubMed  CAS  Google Scholar 

  33. Percell RH, Gerin JL. Hepatitis Delta Virus. In: Fields BN, Knipe DM, Howley PM, ed. Fields Virology. 3rd ed. Philadelphia: Lippincott-Raven; 1996:2819–2829.

    Google Scholar 

  34. Hoofnagle JH. Type D (delta) hepatitis. JAMA. 1989;261(9):1321–1325.

    PubMed  CAS  Google Scholar 

  35. Wu JC, Chen TZ, Huang YS, et al. Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction. Gastroenterology. 1995;108(3):796–802.

    PubMed  CAS  Google Scholar 

  36. Rizzetto M, Verme G, Recchia S, et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med. 1983;98(4):437–441.

    PubMed  CAS  Google Scholar 

  37. Gheorghe L, Iacob S, Simionov I, et al. Natural history of compensated viral B and D cirrhosis. Rom J Gastroenterol. 2005;14(4):329–335.

    PubMed  Google Scholar 

  38. Romeo R, Del Ninno E, Rumi M, et al. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology. 2009;136(5):1629–1638.

    PubMed  Google Scholar 

  39. Su CW, Huang YH, Huo TI, et al. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology. 2006;130(6):1625–1635.

    PubMed  CAS  Google Scholar 

  40. Castellares C, Barreiro P, Martin-Carbonero L, et al. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome. J Viral Hepat. 2008;15(3):165–172.

    PubMed  CAS  Google Scholar 

  41. Sheng WH, Hung CC, Kao JH, et al. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Clin Infect Dis. 2007;44(7):988–995.

    PubMed  Google Scholar 

  42. Wu JC, Choo KB, Chen CM, Chen TZ, Huo TI, Lee SD. Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. Lancet. 1995;346(8980):939–941.

    PubMed  CAS  Google Scholar 

  43. Casey JL, Brown TL, Colan EJ, Wignall FS, Gerin JL. A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci U S A. 1993;90(19):9016–9020.

    PubMed  CAS  Google Scholar 

  44. Bensabath G, Hadler SC, Soares MC, et al. Hepatitis delta virus infection and Labrea hepatitis. Prevalence and role in fulminant hepatitis in the Amazon Basin. JAMA. 1987;258(4):479–483.

    PubMed  CAS  Google Scholar 

  45. Hadler SC, Alcala de Monzon M, Rivero D, Perez M, Bracho A, Fields H. Epidemiology and long-term consequences of hepatitis delta virus infection in the Yucpa Indians of Venezuela. Am J Epidemiol. 1992;136(12):1507–1516.

    PubMed  CAS  Google Scholar 

  46. Shih HH, Jeng KS, Syu WJ, et al. Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus. J Virol. 2008;82(5):2250–2264.

    PubMed  CAS  Google Scholar 

  47. Farci P, Barbera C, Navone C, et al. Infection with the delta agent in children. Gut. 1985;26(1):4–7.

    PubMed  CAS  Google Scholar 

  48. Zuckerman AJ. Prevention of primary liver cancer by immunization. N Engl J Med. 1997;336(26):1906–1907.

    PubMed  CAS  Google Scholar 

  49. Borresen ML, Olsen OR, Ladefoged K, et al. Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland. J Viral Hepat. 2010;17:162–170.

    PubMed  CAS  Google Scholar 

  50. Morcos MM, Mikhail TH, Hanna WM, Abdel-Fattah S, el-Rasad MM, Wassef EL. The prevalence of delta virus infection in chronic liver disease in Egyptian children in comparison with some other countries. Panminerva Med. 2000;42(2):97–100.

    PubMed  CAS  Google Scholar 

  51. Zanetti AR, Ferroni P, Magliano EM, et al. Perinatal transmission of the hepatitis B virus and of the HBV-associated delta agent from mothers to offspring in northern Italy. J Med Virol. 1982;9(2):139–148.

    PubMed  CAS  Google Scholar 

  52. Bichko V, Netter HJ, Wu TT, Taylor J. Pathogenesis associated with replication of hepatitis delta virus. Infect Agents Dis. 1994;3(2–3):94–97.

    PubMed  CAS  Google Scholar 

  53. Nakano T, Shapiro CN, Hadler SC, et al. Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela. J Gen Virol. 2001;82(Pt 9):2183–2189.

    PubMed  CAS  Google Scholar 

  54. Zachou K, Yurdaydin C, Drebber U, et al. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Internat. 2009.

    Google Scholar 

  55. Zachou K, Yurdaydin C, Dienes HE, Dalekos GN, Erhardt A, Cakaloglu Y, Degertekin H, Gurel S, Zeuzem S, Bozkaya H, Bock T, Schlaphoff V, Manns MP, Wedemeyer H. 479 Significance of HDV-RNA and HBsAg levels in delta hepatitis: first data of the Hep-Net/international HDV intervention trial. J Hepatol. 2006;44:S178.

    Google Scholar 

  56. Aragona M, Macagno S, Caredda F, et al. Serological response to the hepatitis delta virus in hepatitis D. Lancet. 1987;1(8531):478–480.

    PubMed  CAS  Google Scholar 

  57. Govindarajan S, Valinluck B, Peters L. Relapse of acute B viral hepatitis – role of delta agent. Gut. 1986;27(1):19–22.

    PubMed  CAS  Google Scholar 

  58. Shattock AG, Morgan BM. Sensitive enzyme immunoassay for the detection of delta antigen and anti-delta, using serum as the delta antigen source. J Med Virol. 1984;13(1):73–82.

    PubMed  CAS  Google Scholar 

  59. Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol. 2010;7(1):31–40.

    PubMed  Google Scholar 

  60. Parana R, Kay A, Molinet F, et al. HDV genotypes in the Western Brazilian Amazon region: a preliminary report. Am J Trop Med Hyg. 2006;75(3):475–479.

    PubMed  CAS  Google Scholar 

  61. Buti M, Esteban R, Jardi R, Esteban JI, Guardia J. Serological diagnosis of acute delta hepatitis. J Med Virol. 1986;18(1):81–85.

    PubMed  CAS  Google Scholar 

  62. Smedile A, Lavarini C, Crivelli O, Raimondo G, Fassone M, Rizzetto M. Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (delta) antigen: clinical significance in delta infection. J Med Virol. 1982;9(2):131–138.

    PubMed  CAS  Google Scholar 

  63. Zignego AL, Deny P, Feray C, et al. Amplification of hepatitis delta virus RNA sequences by polymerase chain reaction: a tool for viral detection and cloning. Mol Cell Probes. 1990;4(1):43–51.

    PubMed  CAS  Google Scholar 

  64. Madejon A, Castillo I, Bartolome J, et al. Detection of HDV-RNA by PCR in serum of patients with chronic HDV infection. J Hepatol. 1990;11(3):381–384.

    PubMed  CAS  Google Scholar 

  65. Dinolfo L, Abate ML, Bertolo P, et al. Detection of hepatitis D virus RNA in serum by a reverse transcription, polymerase chain reaction-based assay. Int J Clin Lab Res. 1995;25(1):35–39.

    PubMed  CAS  Google Scholar 

  66. McFarlane IG, Chaggar K, Davies SE, Smith HM, Alexander GJ, Williams R. IgA class antibodies to hepatitis delta virus antigen in acute and chronic hepatitis delta virus infections. Hepatology. 1991;14(6):980–984.

    PubMed  CAS  Google Scholar 

  67. Rizzetto M, Rosina F, Saracco G, et al. Treatment of chronic delta hepatitis with alpha-2 recombinant interferon. J Hepatol. 1986;3 Suppl 2:S229–S233.

    PubMed  Google Scholar 

  68. Ilan Y, Klein A, Taylor J, Tur-Kaspa R. Resistance of hepatitis delta virus replication to interferon-alpha treatment in transfected human cells. J Infect Dis. 1992;166(5):1164–1166.

    PubMed  CAS  Google Scholar 

  69. McNair AN, Cheng D, Monjardino J, Thomas HC, Kerr IM. Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA. J Gen Virol. 1994;75 ( Pt 6):1371–1378.

    PubMed  CAS  Google Scholar 

  70. Farci P, Mandas A, Coiana A, et al. Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med. 1994;330(2):88–94.

    PubMed  CAS  Google Scholar 

  71. Farci P, Roskams T, Chessa L, et al. Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. Gastroenterology. 2004;126(7):1740–1749.

    PubMed  CAS  Google Scholar 

  72. Niro GA, Rosina F, Rizzetto M. Treatment of hepatitis D. J Viral Hepat. 2005;12(1):2–9.

    PubMed  CAS  Google Scholar 

  73. Yurdaydin C, Bozkaya H, Karaaslan H, et al. A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis. J Viral Hepat. 2007;14(11):812–816.

    PubMed  CAS  Google Scholar 

  74. Castelnau C, Le Gal F, Ripault MP, et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology. 2006;44(3):728–735.

    PubMed  CAS  Google Scholar 

  75. Erhardt A, Gerlich W, Starke C, et al. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Internat. 2006;26(7):805–810.

    CAS  Google Scholar 

  76. Niro GA, Ciancio A, Gaeta GB, et al. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology. 2006;44(3):713–720.

    PubMed  CAS  Google Scholar 

  77. Yurdaydin C, Wedemeyer H, Dalekos G, et al. A multicenter randomised stduy comparing the efficacy of pegylated intereron alfa-2A plus adefovir dipivoxil vs. pegylated intereron alfa-2A plus placebo vs. adefovir dipovoxil for the treatment of chronic delta hepatitis: the intervention trial (HID-IT). Hepatology 2006;41(suppl 1):230A.

    Google Scholar 

  78. Niro GA, Ciancio A, Tillman HL, et al. Lamivudine therapy in chronic delta hepatitis: a ­multicentre randomized-controlled pilot study. Aliment Pharmacol Ther. 2005;22(3):227–232.

    PubMed  CAS  Google Scholar 

  79. Wolters LM, van Nunen AB, Honkoop P, et al. Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus. J Viral Hepat. 2000;7(6):428–434.

    PubMed  CAS  Google Scholar 

  80. Lau DT, Doo E, Park Y, et al. Lamivudine for chronic delta hepatitis. Hepatology. 1999;30(2):546–549.

    PubMed  CAS  Google Scholar 

  81. Gunsar F, Akarca US, Ersoz G, et al. Two-year interferon therapy with or without ribavirin in chronic delta hepatitis. Antivir Ther. 2005;10(6):721–726.

    PubMed  CAS  Google Scholar 

  82. Garripoli A, Di Marco V, Cozzolongo R, et al. Ribavirin treatment for chronic hepatitis D: a pilot study. Liver. 1994;14(3):154–157.

    PubMed  CAS  Google Scholar 

  83. Schneider A, Habermehl P, Gerner P, Lausch E, Ballauff A, Wirth S. Alpha-interferon treatment in HBeAg positive children with chronic hepatitis B and associated hepatitis D. Klin Padiatr. 1998;210(5):363–365.

    PubMed  CAS  Google Scholar 

  84. Dalekos GN, Galanakis E, Zervou E, Tzoufi M, Lapatsanis PD, Tsianos EV. Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience. Hepatogastroenterology. 2000;47(34):1072–1076.

    PubMed  CAS  Google Scholar 

  85. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med. 1993;329(25):1842–1847.

    PubMed  CAS  Google Scholar 

  86. Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 1983;20(1):23–31.

    PubMed  CAS  Google Scholar 

  87. Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 1990;247(4948):1335–1339.

    PubMed  CAS  Google Scholar 

  88. Tsarev SA, Emerson SU, Reyes GR, et al. Characterization of a prototype strain of hepatitis E virus. Proc Natl Acad Sci U S A. 1992;89(2):559–563.

    PubMed  CAS  Google Scholar 

  89. Tam AW, Smith MM, Guerra ME, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology. 1991;185(1):120–131.

    PubMed  CAS  Google Scholar 

  90. Ansari IH, Nanda SK, Durgapal H, et al. Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1). J Med Virol. 2000;60(3):275–283.

    PubMed  CAS  Google Scholar 

  91. Krawczynski K, Bradley DW. Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques. J Infect Dis. 1989;159(6):1042–1049.

    PubMed  CAS  Google Scholar 

  92. Worm HC, van der Poel WH, Brandstatter G. Hepatitis E: an overview. Microbes Infect. 2002;4(6):657–666.

    PubMed  CAS  Google Scholar 

  93. Aggarwal R, Krawczynski K. Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol. 2000;15(1):9–20.

    PubMed  CAS  Google Scholar 

  94. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol. 2006;16(1):5–36.

    PubMed  CAS  Google Scholar 

  95. Huang CC, Nguyen D, Fernandez J, et al. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology. 1992;191(2):550–558.

    PubMed  CAS  Google Scholar 

  96. van Cuyck-Gandre H, Zhang HY, Tsarev SA, et al. Characterization of hepatitis E virus (HEV) from Algeria and Chad by partial genome sequence. J Med Virol. 1997;53(4):340–347.

    PubMed  Google Scholar 

  97. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008;8(11):698–709.

    PubMed  Google Scholar 

  98. Wang Y, Ling R, Erker JC, et al. A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis. J Gen Virol. 1999;80 ( Pt 1):169–177.

    PubMed  CAS  Google Scholar 

  99. Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ. 1992;70(5):597–604.

    PubMed  CAS  Google Scholar 

  100. Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human ­hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med. 1980;68(6):818–824.

    PubMed  CAS  Google Scholar 

  101. Kane MA, Bradley DW, Shrestha SM, et al. Epidemic non-A, non-B hepatitis in Nepal. Recovery of a possible etiologic agent and transmission studies in marmosets. JAMA. 1984;252(22):3140–3145.

    PubMed  CAS  Google Scholar 

  102. Tsega E, Hansson BG, Krawczynski K, Nordenfelt E. Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy. Clin Infect Dis. 1992;14(4):961–965.

    PubMed  CAS  Google Scholar 

  103. Aggarwal R, Shahi H, Naik S, Yachha SK, Naik SR. Evidence in favour of high infection rate with hepatitis E virus among young children in India. J Hepatol. 1997;26(6):1425–1426.

    PubMed  CAS  Google Scholar 

  104. Aggarwal R, Naik SR. Hepatitis E: does person-to-person spread occur? Indian J Gastroenterol. 1992;11(3):109–112.

    PubMed  CAS  Google Scholar 

  105. Somani SK, Aggarwal R, Naik SR, Srivastava S, Naik S. A serological study of intrafamilial spread from patients with sporadic hepatitis E virus infection. J Viral Hepat. 2003;10(6):446–449.

    PubMed  CAS  Google Scholar 

  106. Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol. 2004;19(7):778–784.

    PubMed  Google Scholar 

  107. Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang. 2000;79(2):72–74.

    PubMed  CAS  Google Scholar 

  108. Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion. 2004;44(6):934–940.

    PubMed  Google Scholar 

  109. Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr. 2003;70(1):37–39.

    PubMed  Google Scholar 

  110. Velazquez O, Stetler HC, Avila C, et al. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986–1987. JAMA. 1990;263(24):3281–3285.

    PubMed  CAS  Google Scholar 

  111. Belabbes EH, Bouguermouh A, Benatallah A, Illoul G. Epidemic non-A, non-B viral hepatitis in Algeria: strong evidence for its spreading by water. J Med Virol. 1985;16(3):257–263.

    PubMed  CAS  Google Scholar 

  112. Tsega E, Krawczynski K, Hansson BG, et al. Outbreak of acute hepatitis E virus infection among military personnel in northern Ethiopia. J Med Virol. 1991;34(4):232–236.

    PubMed  CAS  Google Scholar 

  113. Nicand E, Armstrong GL, Enouf V, et al. Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad. J Med Virol. 2005;77(4):519–521.

    PubMed  CAS  Google Scholar 

  114. Meng XJ. Hepatitis E virus: animal reservoirs and zoonotic risk. Vet Microbiol. 2009;140(3–4):256–265.

    PubMed  Google Scholar 

  115. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet. 2003;362(9381):371–373.

    PubMed  Google Scholar 

  116. Li TC, Chijiwa K, Sera N, et al. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis. 2005;11(12):1958–1960.

    PubMed  Google Scholar 

  117. Wichmann O, Schimanski S, Koch J, et al. Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis. 2008;198(12):1732–1741.

    PubMed  Google Scholar 

  118. Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol. 2002;40(1):117–122.

    PubMed  CAS  Google Scholar 

  119. Banks M, Bendall R, Grierson S, Heath G, Mitchell J, Dalton H. Human and porcine hepatitis E virus strains, United Kingdom. Emerg Infect Dis. 2004;10(5):953–955.

    PubMed  Google Scholar 

  120. Karetnyi YV, Gilchrist MJ, Naides SJ. Hepatitis E virus infection prevalence among selected populations in Iowa. J Clin Virol. 1999;14(1):51–55.

    PubMed  CAS  Google Scholar 

  121. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988–1994. J Infect Dis. 2009;200(1):48–56.

    PubMed  Google Scholar 

  122. Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet. 1995;345(8956):1025–1026.

    PubMed  CAS  Google Scholar 

  123. Kumar RM, Uduman S, Rana S, Kochiyil JK, Usmani A, Thomas L. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol. 2001;100(1):9–15.

    PubMed  CAS  Google Scholar 

  124. Chau TN, Lai ST, Tse C, et al. Epidemiology and clinical features of sporadic hepatitis E as compared with hepatitis A. Am J Gastroenterol. 2006;101(2):292–296.

    PubMed  Google Scholar 

  125. Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI. Incidence and severity of viral hepatitis in pregnancy. Am J Med. 1981;70(2):252–255.

    PubMed  CAS  Google Scholar 

  126. Hamid SS, Atiq M, Shehzad F, et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology. 2002;36(2):474–478.

    PubMed  Google Scholar 

  127. Kumar Acharya S, Kumar Sharma P, Singh R, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol. 2007;46(3):387–394.

    PubMed  Google Scholar 

  128. Haagsma EB, van den Berg AP, Porte RJ, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2008;14(4):547–553.

    PubMed  Google Scholar 

  129. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358(8):811–817.

    PubMed  CAS  Google Scholar 

  130. Ollier L, Tieulie N, Sanderson F, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med. 2009;150(6):430–431.

    PubMed  Google Scholar 

  131. Chauhan A, Jameel S, Dilawari JB, Chawla YK, Kaur U, Ganguly NK. Hepatitis E virus transmission to a volunteer. Lancet. 1993;341(8838):149–150.

    PubMed  CAS  Google Scholar 

  132. Favorov MO, Fields HA, Purdy MA, et al. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol. 1992;36(4):246–250.

    PubMed  CAS  Google Scholar 

  133. Arora NK, Panda SK, Nanda SK, et al. Hepatitis E infection in children: study of an outbreak. J Gastroenterol Hepatol. 1999;14(6):572–577.

    PubMed  CAS  Google Scholar 

  134. de Groen PC. Hepatitis E in the United States: a case of “hog fever”? Mayo Clin Proc. 1997;72(12):1197–1198.

    PubMed  Google Scholar 

  135. Kar P, Jilani N, Husain SA, et al. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Am J Gastroenterol. 2008;103(10):2495–2501.

    PubMed  CAS  Google Scholar 

  136. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007;147(1):28–33.

    PubMed  Google Scholar 

  137. Bhatia V, Singhal A, Panda SK, Acharya SK. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology. 2008;48(5):1577–1585.

    PubMed  Google Scholar 

  138. Gerolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med. 2008;358(8):859–860.

    PubMed  CAS  Google Scholar 

  139. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361(10):1025–1027.

    PubMed  CAS  Google Scholar 

  140. Soe S, Uchida T, Suzuki K, et al. Enterically transmitted non-A, non-B hepatitis in cynomolgus monkeys: morphology and probable mechanism of hepatocellular necrosis. Liver. 1989;9(3):135–145.

    PubMed  CAS  Google Scholar 

  141. Gupta DN, Smetana HF. The histopathology of viral hepatitis as seen in the Delhi epidemic (1955–56). Indian J Med Res. 1957;45(Suppl.):101–113.

    PubMed  CAS  Google Scholar 

  142. Asher LV, Innis BL, Shrestha MP, Ticehurst J, Baze WB. Virus-like particles in the liver of a patient with fulminant hepatitis and antibody to hepatitis E virus. J Med Virol. 1990;31(3):229–233.

    PubMed  CAS  Google Scholar 

  143. Clayson ET, Myint KS, Snitbhan R, et al. Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E. J Infect Dis. 1995;172(4):927–933.

    PubMed  CAS  Google Scholar 

  144. Bryan JP, Tsarev SA, Iqbal M, et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis. 1994;170(3):517–521.

    PubMed  CAS  Google Scholar 

  145. Favorov MO, Khudyakov YE, Mast EE, et al. IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein. J Med Virol. 1996;50(1):50–58.

    PubMed  CAS  Google Scholar 

  146. Gyarmati P, Mohammed N, Norder H, Blomberg J, Belak S, Widen F. Universal detection of hepatitis E virus by two real-time PCR assays: TaqMan and Primer-Probe Energy Transfer. J Virol Methods. 2007;146(1–2):226–235.

    PubMed  CAS  Google Scholar 

  147. Joshi YK, Babu S, Sarin S, Tandon BN, Gandhi BM, Chaturvedi VC. Immunoprophylaxis of epidemic non-A non-B hepatitis. Indian J Med Res. 1985;81:18–19.

    PubMed  CAS  Google Scholar 

  148. Khuroo MS, Dar MY. Hepatitis E: evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol. 1992;11(3):113–116.

    PubMed  CAS  Google Scholar 

  149. Tsarev SA, Tsareva TS, Emerson SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A. 1994;91(21):10198–10202.

    PubMed  CAS  Google Scholar 

  150. Bile K, Isse A, Mohamud O, et al. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg. 1994;51(4):466–474.

    PubMed  CAS  Google Scholar 

  151. Corwin AL, Khiem HB, Clayson ET, et al. A waterborne outbreak of hepatitis E virus transmission in southwestern Vietnam. Am J Trop Med Hyg. 1996;54(6):559–562.

    PubMed  CAS  Google Scholar 

  152. Aggarwal R, Naik SR. Hepatitis E: intrafamilial transmission versus waterborne spread. J Hepatol. 1994;21(5):718–723.

    PubMed  CAS  Google Scholar 

  153. Khuroo MS. Hepatitis E: the enterically transmitted non-A, non-B hepatitis. Indian J Gastroenterol. 1991;10(3):96–100.

    PubMed  CAS  Google Scholar 

  154. Hong Y, Ruan B, Yang LH, et al. Hepatitis E virus chimeric DNA vaccine elicits immunologic response in mice. World J Gastroenterol. 2005;11(42):6713–6715.

    PubMed  Google Scholar 

  155. Zhang M, Emerson SU, Nguyen H, et al. Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques. Vaccine. 2002;20(27–28):3285–3291.

    PubMed  CAS  Google Scholar 

  156. Purcell RH, Nguyen H, Shapiro M, et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine. 2003;21(19–20):2607–2615.

    PubMed  CAS  Google Scholar 

  157. Zhou YX, Lee MY, Ng JM, et al. A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice. World J Gastroenterol. 2006;12(2):306–312.

    PubMed  CAS  Google Scholar 

  158. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007;356(9):895–903.

    PubMed  CAS  Google Scholar 

  159. Zhang J, Liu CB, Li RC, et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine. 2009;27(12):1869–1874.

    PubMed  CAS  Google Scholar 

  160. Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol. 2009;24(9):1484–1493.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rima Fawaz .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Fawaz, R. (2010). Hepatitis D and Hepatitis E in Children. In: Jonas, M. (eds) Viral Hepatitis in Children. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-373-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-373-2_6

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-372-5

  • Online ISBN: 978-1-60761-373-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics